Trial Profile

A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of RT-114 in Healthy Volunteers

Status: Not yet recruiting

Phase of Trial: Phase I

Latest Information Update: 03 Apr 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs PG 102 (Primary) ; PG 102 (Primary)
Indications Obesity
Focus Adverse reactions
Sponsors Rani Therapeutics

Most Recent Events

31 Mar 2025 According to a Rani Therapeutics Holdings Inc media release, a Phase 1 program is expected to initiate in mid 2025.
28 Mar 2025 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health : NCT06891287).
03 Jul 2024 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com